Author
Listed:
- Suguru Saito
(Division of Clinical Nephrology and Rheumatology, Graduate School of Medical and Dental Sciences, Kidney Research Center, Niigata University, Niigata 9518510, Japan
Department of Bio Medical Science, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
Institute of Biomedical Science, Academia Sinica, Taipei 115, Taiwan)
- Su-Hui Lin
(Institute of Biomedical Science, Academia Sinica, Taipei 115, Taiwan
Department of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA)
- Hui-Ya Wu
(Department of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
College of Health Science, Trans World University, Yunlin 640, China
Medical Science International, Yamagata 9980811, Japan)
Abstract
Background and objectives: Lipoteichoic acid (LTA) is a structural component of Staphylococcus aureus ( S. aureus ) that induces severe infection disease and skin inflammation such as atopic dermatitis (AD); the biological function of LTA is still unclear. Dendritic cells (DC) are important regulators in the immune system, and the cells ectopically recognize agents that have an influence on the host immune response. We aimed to reveal the DC-based immune response against LTA to understand the novel mechanism in S. aureus related acute skin inflammation. Materials and Methods: Different doses of LTA were applied on the epidermal barrier dysfunction mice in order to evaluate the epidermal thickness, DC activation, and subsequent immunological response such as effector T-cell (Teff) activation. In addition, bone marrow-derived dendritic cells (BMDCs) were also treated with LTA, and the immunoregulatory mechanism was investigated. Results: A low dose of LTA did not induce skin inflammation at all; however, a high dose of LTA induced severe skin inflammation on epidermalba rrier dysfunction mice. Those symptoms were correlated with the DC and Teff activation status. The low-dose treatment of LTA showed a suppressive effect in pro-inflammatory cytokine production via a Toll-like receptor 2 (TLR2)-dominant manner, and the effect was significant regarding the co-treatment with another stimulatory signal such as TLR4 by lipopolysaccharide (LPS). Meanwhile, a high-dose treatment of LTA completely abolished the suppressive effect of a low-dose treatment. This phenomenon was based on C-type lectin receptors (CLRs), because the high dose of LTA greatly enhanced the expression of CLRs in the activated DCs. Conclusions: DCs sensed the dose difference of LTA, and the mechanism contributed to regulating immune responses such as effector T-cell activation, which was directly correlated with inflammatory response. This finding might provide an understanding for the novel immunological effect of LTA and S. aureus pathogenesis under inflammation, as well as the mechanism of symbiosis.
Suggested Citation
Suguru Saito & Su-Hui Lin & Hui-Ya Wu, 2019.
"The Unique Immunoregulatory Function of Staphylococcus Aureus Lipoteichoic Acid in Dendritic Cells,"
J, MDPI, vol. 2(3), pages 1-14, August.
Handle:
RePEc:gam:jjopen:v:2:y:2019:i:3:p:22-339:d:256031
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jjopen:v:2:y:2019:i:3:p:22-339:d:256031. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.